Legend Biotech (LEGN) Receivables - Other (2019 - 2024)
Historic Receivables - Other for Legend Biotech (LEGN) over the last 6 years, with Q4 2024 value amounting to $780000.0.
- Legend Biotech's Receivables - Other fell 126.58% to $780000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $780000.0, marking a year-over-year decrease of 126.58%. This contributed to the annual value of $780000.0 for FY2024, which is 126.58% down from last year.
- Legend Biotech's Receivables - Other amounted to $780000.0 in Q4 2024, which was down 126.58% from $790000.0 recorded in Q4 2023.
- In the past 5 years, Legend Biotech's Receivables - Other registered a high of $50.0 million during Q4 2021, and its lowest value of $619000.0 during Q4 2020.
- Moreover, its 5-year median value for Receivables - Other was $785000.0 (2023), whereas its average is $9.0 million.
- Per our database at Business Quant, Legend Biotech's Receivables - Other skyrocketed by 797754.44% in 2021 and then tumbled by 9810.4% in 2022.
- Quarter analysis of 5 years shows Legend Biotech's Receivables - Other stood at $619000.0 in 2020, then soared by 7977.54% to $50.0 million in 2021, then tumbled by 98.1% to $948000.0 in 2022, then fell by 16.67% to $790000.0 in 2023, then decreased by 1.27% to $780000.0 in 2024.
- Its last three reported values are $780000.0 in Q4 2024, $790000.0 for Q4 2023, and $948000.0 during Q4 2022.